Pei Lin
Hebei Medical University(CN)The University of Texas MD Anderson Cancer Center(US)Peking University(CN)Sichuan University(CN)West China Hospital of Sichuan University(CN)Guangdong Province Stomatological Hospital(CN)Fourth Hospital of Hebei Medical University(CN)Hebei University of Chinese Medicine(CN)Hope Center for Neurological Disorders(US)Peking University People's Hospital(CN)Affiliated Hospital of Hebei University(CN)Hebei Academy of Sciences(CN)First Affiliated Hospital of Hebei Medical University(CN)Southern Medical University(CN)Beijing University of Chemical Technology(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Pathogenic Germline Variants in 10,389 Adult Cancers(2018)866 cited
- → Double hit lymphoma: the MD A nderson C ancer C enter clinical experience(2014)362 cited
- → Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype(2016)340 cited
- → B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome(2011)246 cited
- → Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis(2005)209 cited
- → Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting(2015)184 cited